Valuation: Harbin Pharmaceutical Group Co., Ltd.

Market Cap 9.34B 1.38B 1.21B 1.12B 1.03B 1.95B 132B 1.99B 13.34B 5.23B 64.77B 5.17B 5.06B 224B P/E 2026 *
20.6x
P/E 2027 * 17.7x
Enterprise Value 9.34B 1.38B 1.21B 1.12B 1.03B 1.95B 132B 1.99B 13.34B 5.23B 64.77B 5.17B 5.06B 224B EV / Sales 2026 *
0.57x
EV / Sales 2027 * 0.55x
Free-Float
47.74%
Yield 2026 *
-
Yield 2027 * -
1 day+10.09%
1 week+18.15%
Current month+24.08%
1 month+17.41%
3 months-1.33%
6 months+4.21%
Current year+7.54%
1 week 3.03
Extreme 3.03
3.71
1 month 2.84
Extreme 2.84
3.71
Current year 2.84
Extreme 2.84
4.88
1 year 2.84
Extreme 2.84
4.88
3 years 2.41
Extreme 2.41
4.97
5 years 2.41
Extreme 2.41
4.97
10 years 2.38
Extreme 2.38
9.77
Manager TitleAgeSince
Chief Executive Officer 64 2023-12-26
Director of Finance/CFO 54 2004-12-23
Investor Relations Contact 45 2022-04-26
Director TitleAgeSince
Director/Board Member 60 2020-11-30
Director/Board Member 60 2021-01-07
Chairman 56 2023-12-26
Date Insider Type Main position Quantity % Market Cap.
24-06-30Sell

Director

22,500 0.0009%
24-06-30Sell 150,000 0.0060%
24-06-30Sell 27,000 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
+10.09%+18.15%-3.89%+16.67% 1.25B
-0.00%-0.99%+48.65%+173.34% 1,060B
+0.58%-0.42%+64.67%+62.60% 619B
-0.79%-3.43%+28.45%+84.15% 438B
-1.75%-0.33%+28.33%+23.58% 333B
+0.24%-0.42%+29.19%+47.26% 282B
-1.75%-10.57%+18.27%+22.07% 267B
+0.67%+1.03%-26.81%-37.96% 218B
-1.76%-2.74%+19.99%+56.55% 196B
+0.50%+0.43%+16.13%+69.68% 161B
Average +0.65%-0.92%+22.30%+51.79% 357.52B
Weighted average by Cap. -0.26%-3.09%+35.59%+84.04%

Financials

2026 *2027 *
Net sales 16.4B 2.42B 2.12B 1.97B 1.81B 3.42B 232B 3.49B 23.42B 9.19B 114B 9.08B 8.89B 393B 16.94B 2.5B 2.19B 2.03B 1.87B 3.53B 239B 3.6B 24.19B 9.49B 117B 9.38B 9.18B 406B
Net income 452M 66.68M 58.48M 54.16M 49.84M 94.26M 6.38B 96.1M 646M 253M 3.13B 250M 245M 10.82B 520M 76.75M 67.32M 62.35M 57.37M 109M 7.35B 111M 743M 291M 3.61B 288M 282M 12.46B
Net Debt - -
Logo Harbin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the research and development, manufacturing, wholesale and retail of pharmaceutical. The Company is mainly engaged in two businesses. The pharmaceutical industry business is mainly engaged in the research, development and manufacturing of chemical raw materials, chemical preparations, biological preparations, traditional Chinese medicine and health care products. The pharmaceutical commercial business is mainly engaged in pharmaceutical commercial wholesale business and pharmaceutical commercial retail business. The Company's products mainly include zinc gluconate oral solution, calcium iron zinc oral solution, compound calcium gluconate oral solution, amoxicillin capsules and Shuanghuanglian oral solution. The Company's products are mainly used in digestive, respiratory, anti-infectious, cardiovascular and cerebrovascular and anti-tumor treatment fields.
Employees
10,039
Date Price Change Volume
26-07-12 CN¥3.710 +10.09% 201,366,400
26-07-10 CN¥3.370 +10.13% 100,032,231
26-07-09 CN¥3.060 -0.97% 38,340,339
26-07-08 CN¥3.090 +0.65% 38,022,151
26-07-07 CN¥3.070 -3.46% 47,922,107
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.370CNY
Average target price
4.310CNY
Spread / Average Target
+27.89%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600664 Stock